The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The G Protein-Coupled Receptors (GPCR) Structure-Based Drug Design Market During The Forecast Period 2026–2030?
The market size for g protein-coupled receptors (gpcr) structure-based drug design has seen rapid expansion in recent years. This market is expected to grow from $2.64 billion in 2025 to $3 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.3%. The growth observed in the past can be attributed to several factors, including advancements in gpcr crystallography techniques, increased pharmaceutical research and development spending, the availability of high-resolution receptor structures, a deeper understanding of gpcr signaling pathways, and the expansion of small molecule drug discovery platforms.
The g protein-coupled receptors (gpcr) structure-based drug design market size is poised for significant expansion in the coming years, projected to reach $4.89 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.0%. This anticipated growth is driven by factors such as the increasing adoption of AI-assisted molecular design, a stronger emphasis on precision medicine drug development, the broadening of gpcr targets in oncology and neurology, rising investments in next-generation structural biology tools, and a growing demand for highly selective therapeutics. Key trends during this period involve the expanding use of structure-guided ligand optimization, the increasing application of cryo-electron microscopy for gpcr analysis, a greater integration of computational modeling in drug discovery, the expansion of allosteric modulator development, and an enhanced focus on improving receptor selectivity.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28229&type=smp
What Drivers Are Expected To Influence The G Protein-Coupled Receptors (GPCR) Structure-Based Drug Design Market During The Forecast Period?
The future expansion of the G protein-coupled receptors (GPCR) structure-based drug design market is anticipated due to the rising need for precision medicine. Precision medicine refers to therapeutic strategies that leverage distinct biological indicators to direct the selection and creation of treatments customized for individual patient traits and disease patterns. The growing adoption of precision medicine stems from its enhanced effectiveness and fewer adverse reactions compared to conventional therapies, as healthcare increasingly favors personalized methods focusing on specific molecular pathways over general interventions. This heightened focus on precision medicine directly boosts the uptake of GPCR structure-based drug design platforms, given the increasing need among pharmaceutical firms for advanced computational instruments to pinpoint and refine receptor-specific compounds that achieve the molecular exactitude required for personalized treatment methods. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA sanctioned 16 novel personalized therapies for rare disease patients, marking a substantial rise from the 6 approvals in 2022. Of these recently approved treatments, 7 are oncology drugs, with 3 targeting other illnesses and conditions. Consequently, the expanding need for precision medicine is fueling the expansion of the G protein-coupled receptors (GPCR) structure-based drug design market.
What Market Segments Are Evaluated Within The G Protein-Coupled Receptors (GPCR) Structure-Based Drug Design Market?
The g protein-coupled receptors (gpcr) structure-based drug design market covered in this report is segmented –
1) By Drug Type: Small Molecule Drugs, Biologics, Peptides, Other Drug Types
2) By Technology: X-Ray Crystallography, Cryo-Electron Microscopy, Computational Modeling, Nuclear Magnetic Resonance Spectroscopy, Other Technologies
3) By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Metabolic Disorders, Other Applications
4) By End-User: Pharmaceutical Companies, Biotechnology Companies, Academic And Research Institutes, Other End-Users
Subsegments:
1) By Small Molecule Drugs: Agonists, Antagonists, Allosteric Modulators, Enzyme Inhibitors
2) By Biologics: Monoclonal Antibodies, Therapeutic Proteins, Vaccines, Fusion Proteins
3) By Peptides: Linear Peptides, Cyclic Peptides, Modified Peptides, Peptidomimetics
4) By Other Drug Types: Nucleic Acid Based Drugs, Cell Based Therapies, Gene Therapies, Conjugated Drugs
What Industry Trends Are Redefining The G Protein-Coupled Receptors (GPCR) Structure-Based Drug Design Market?
Major companies active in the G-protein coupled receptor (GPCR) structure-based drug design market are concentrating on developing innovative solutions, such as structure-based drug design platforms, to accelerate novel drug discovery and enhance therapeutic targeting. Structure-based drug design platforms are computational and experimental instruments that leverage the three-dimensional (3D) structure of target proteins to design and optimize drug candidates, aiding in the identification of more precise, effective, and safer treatments. For instance, in January 2025, Septerna Inc., a US-based pharmaceutical company, launched new initiatives to advance its Native Complex Platform, building upon the $100 million Series A financing it had secured. This platform enables structure-based drug design for GPCRs by maintaining their native structure and dynamics outside the cellular environment, supporting the development of a pipeline of GPCR-targeted therapies aimed at previously undruggable targets across multiple therapeutic areas. It also provides a scalable foundation for industrialized drug discovery, the integration of novel screening technologies, and the discovery of new mechanisms of GPCR modulation. Additionally, the platform creates opportunities to systematically explore the entire GPCR superfamily, thereby opening the door to a wider array of therapeutic interventions.
Who Are The Top Market Participants Influencing The G Protein-Coupled Receptors (GPCR) Structure-Based Drug Design Market?
Major companies operating in the g protein-coupled receptors (gpcr) structure-based drug design market are F. Hoffmann-La Roche Ltd., Pfizer Inc., Sanofi S.A., AstraZeneca plc, Thermo Fisher Scientific Inc., Boehringer Ingelheim International GmbH, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., Evotec SE, Acadia Pharmaceuticals Inc., Promega Corporation, Domain Therapeutics SA, Schrödinger Inc., Kallyope Inc., Domainex Ltd., Structure Therapeutics Inc., Creative Biolabs Inc., InterAx Biotech Inc., Abalone Bio Inc., Octant Inc.
Read the full g protein-coupled receptors (gpcr) structure-based drug design market report here:
Which Region Is Forecast To Lead The G Protein-Coupled Receptors (GPCR) Structure-Based Drug Design Market In Terms Of Market Size?
North America was the largest region in the G protein-coupled receptors (GPCR) structure-based drug design market in 2025. The regions covered in the g protein-coupled receptors (gpcr) structure-based drug design market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored G Protein-Coupled Receptors (GPCR) Structure-Based Drug Design Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=28229&type=smp
Browse Through More Reports Similar to the Global G Protein-Coupled Receptors (GPCR) Structure-Based Drug Design Market 2026, By The Business Research Company
G Protein Coupled Receptors Market Report 2026
https://www.thebusinessresearchcompany.com/report/g-protein-coupled-receptors-global-market-report
Bioengineered Protein Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/bioengineered-protein-drugs-global-market-report
Glp 1 Receptor Agonist Market Report 2026
https://www.thebusinessresearchcompany.com/report/glp-1-receptor-agonist-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model